Fungal endocarditis accounts for 1% to 3% of all infective endocarditis cases, is associated
with high morbidity and mortality (> 70%), and presents numerous challenges during clinical …

Aspergillus flavus is the second most common etiological agent of invasive aspergillosis (IA)
after A. fumigatus. However, most literature describes IA in relation to A. fumigatus or …

Aspergillus infections have grown in importance in the last years. However, most of the
studies have focused on Aspergillus fumigatus, the most prevalent species in the genus. In …

We describe a large series of patients with chronic obstructive pulmonary disease (COPD)
and probable invasive pulmonary aspergillosis (IPA), and the risk factors and incidence of …

We present the genome sequences of a new clinical isolate of the important human
pathogen, Aspergillus fumigatus, A1163, and two closely related but rarely pathogenic …

Data regarding the incidence of invasive aspergillosis (IA) in the intensive care unit (ICU)
are scarce, and the incidence varies. An incidence of 5.8% in a medical ICU has been …

Osteoarticular mycoses are chronic debilitating infections that require extended courses of
antifungal therapy and may warrant expert surgical intervention. As there has been no …

Invasive fungal infections are a growing problem in critically ill patients and are associated
with increased morbidity and mortality. Most of them are due to Candida species, especially …

Despite improvements in the antifungal armamentarium and diagnostic modalities, invasive
aspergillosis (IA) remains an important cause of morbidity and mortality in …

Most of the information available about Aspergillus infections has originated from the study
of A. fumigatus, the most frequent species in the genus. This review aims to compare the …